Search results

Selected filters:

Analysis
University & Research Institutions

Article type

Topic

Sector

Regions

Year

145 results found for your search

Sort options
05 December 2019

Biologics exclusivity may be sacrificed to seal NAFTA 2.0 deal

Trump administration said to be considering weakening provisions to break political gridlock over USMCA

04 December 2019

What leaked US trade talks tell us about future of UK pharma IP

Secret government documents detailing pharma patent discussions between UK and US officials have stirred up a controversy in the run up to the British general election later this month

29 November 2019

NTT looks for global growth in innovation and patents

Under new CEO Jun Sawada, the Japanese IT giant is planning to compete directly across various technology areas with powerhouses such as Alphabet and Apple  

27 November 2019

FDA takes rare step of revoking orphan drug status

The decision means that Indivior’s Sublocade is no longer eligible for lucrative exclusivity, but leaves concerns about evergreening unaddressed

21 November 2019

US Presidential hopefuls set their sights on pharma patents

With several leading Democratic candidates threatening to circumvent pharma IP, next year’s election could prove pivotal for right owners

19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

12 November 2019

Korean NPE launches offensive after streaming pool's collapse

State research lab ETRI and patent fund Intellectual Discovery are two of the entities in line to profit from the assertion effort

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

06 November 2019

Chinese patents surviving validity challenges in greater numbers

Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate

24 October 2019

Latest statistics show foreign firms win in high numbers at Beijing IP Court

Numbers also show that damages are rising. But litigation statistics only tell part of the story on plaintiff success.

16 October 2019

WIPO report: US patent filings dip for first time since 2009

The number of grants also drops while UK sees worrying fall in applications; but study has good news for EPO President Campinos

11 October 2019

Fractus expands litigation campaign to Delhi

European developer of antenna tech opened up a new front against Chinese smartphone companies in India earlier this year. Unlicensed brands have taken over a larger share of India's smartphone market in recent years

09 October 2019

Intel can’t knock out Chinese state lab’s chip patent

Invalidation efforts in both China and the United States have come up short as the US chip giant faces Chinese infringement claims

08 October 2019

Patent commercialisation when you have 300 CEOs

Senior executives from CalTech, Stanford, Battelle and Rambus share their thoughts on the changing state of play in tech transfer